| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |